Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Safran

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Critical Reviews in Oncology/Hematology|July 6, 2002
Paclitaxel as a radiation sensitizer for locally advanced pancreatic cancerHoward Safran, Ritesh Rathore
Medicine and Health, Rhode Island|July 10, 2002
Evaluation and treatment of hepatic metastases from unknown GI primaryNadia Ramdin, Howard Safran
Future Oncology (London, England)|March 5, 2016
Optimizing initial chemotherapy for metastatic pancreatic cancerKalyan C Mantripragada, Howard Safran
Current Oncology Reports|April 2, 2003
Status of treatment for advanced gastric carcinomaJames Y Tsai, Howard Safran
Cancer Investigation|January 23, 2004
Paclitaxel and concurrent radiation in upper gastrointestinal cancersMaria Constantinou, James Y Tsai, Howard Safran
Rhode Island Medical Journal (2013)|October 1, 2015
Mutation Profiling of Clinically Advanced Cancers Using Next-Generation Sequencing for Targeted Therapy: A Lifespan ExperienceKenneth Friedman, Murray B Resnick, Howard Safran
Medicine and Health, Rhode Island|July 15, 2004
Chemotherapy for pancreatic cancerJames Y Tsai, Ahmed Nadeem, Howard Safran
Seminars in Oncology|August 9, 2003
Combined modality therapy for pancreatic cancerJames Y Tsai, David A Iannitti, Howard Safran
Expert Opinion on Therapeutic Targets|February 15, 2007
HER family inhibitors in pancreatic cancer: current status and future directionsDavid Berz, Thomas Miner, Elise McCormack, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
CRE25-047: Avapritinib Induced Pseudoprogression in a Gastrointestinal Stromal Tumor With a PDGFRA Exam 18 842 MutationCharmi Trivedi, Timothy Murtha, Zane Zaidi, et al.
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Critical Reviews in Oncology/Hematology|July 6, 2002
Paclitaxel as a radiation sensitizer for locally advanced pancreatic cancerHoward Safran, Ritesh Rathore
Medicine and Health, Rhode Island|July 10, 2002
Evaluation and treatment of hepatic metastases from unknown GI primaryNadia Ramdin, Howard Safran
Future Oncology (London, England)|March 5, 2016
Optimizing initial chemotherapy for metastatic pancreatic cancerKalyan C Mantripragada, Howard Safran
Current Oncology Reports|April 2, 2003
Status of treatment for advanced gastric carcinomaJames Y Tsai, Howard Safran
Cancer Investigation|January 23, 2004
Paclitaxel and concurrent radiation in upper gastrointestinal cancersMaria Constantinou, James Y Tsai, Howard Safran
Rhode Island Medical Journal (2013)|October 1, 2015
Mutation Profiling of Clinically Advanced Cancers Using Next-Generation Sequencing for Targeted Therapy: A Lifespan ExperienceKenneth Friedman, Murray B Resnick, Howard Safran
Medicine and Health, Rhode Island|July 15, 2004
Chemotherapy for pancreatic cancerJames Y Tsai, Ahmed Nadeem, Howard Safran
Seminars in Oncology|August 9, 2003
Combined modality therapy for pancreatic cancerJames Y Tsai, David A Iannitti, Howard Safran
Expert Opinion on Therapeutic Targets|February 15, 2007
HER family inhibitors in pancreatic cancer: current status and future directionsDavid Berz, Thomas Miner, Elise McCormack, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
CRE25-047: Avapritinib Induced Pseudoprogression in a Gastrointestinal Stromal Tumor With a PDGFRA Exam 18 842 MutationCharmi Trivedi, Timothy Murtha, Zane Zaidi, et al.
Pageof 12